These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26817443)

  • 1. Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study.
    Kühn T; Floegel A; Sookthai D; Johnson T; Rolle-Kampczyk U; Otto W; von Bergen M; Boeing H; Kaaks R
    BMC Med; 2016 Jan; 14():13. PubMed ID: 26817443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.
    Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Floegel A; Boeing H; Trichopoulou A; Lagiou P; Anifantis E; Agnoli C; Palli D; Trevisan M; Tumino R; Bueno-de-Mesquita HB; Agudo A; Larrañaga N; Redondo-Sánchez D; Barricarte A; Huerta JM; Quirós JR; Wareham N; Khaw KT; Perez-Cornago A; Johansson M; Cross AJ; Tsilidis KK; Riboli E; Key TJ; Travis RC
    BMC Med; 2017 Jul; 15(1):122. PubMed ID: 28676103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Harewood R; Rothwell JA; Bešević J; Viallon V; Achaintre D; Gicquiau A; Rinaldi S; Wedekind R; Prehn C; Adamski J; Schmidt JA; Jacobs I; Tjønneland A; Olsen A; Severi G; Kaaks R; Katzke V; Schulze MB; Prada M; Masala G; Agnoli C; Panico S; Sacerdote C; Jakszyn PG; Sánchez MJ; Castilla J; Chirlaque MD; Atxega AA; van Guelpen B; Heath AK; Papier K; Tong TYN; Summers SA; Playdon M; Cross AJ; Keski-Rahkonen P; Chajès V; Murphy N; Gunter MJ
    EBioMedicine; 2024 Mar; 101():105024. PubMed ID: 38412638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-Related Metabolomic Profiles and Discrimination of Metabolically Unhealthy Obesity.
    Bagheri M; Farzadfar F; Qi L; Yekaninejad MS; Chamari M; Zeleznik OA; Kalantar Z; Ebrahimi Z; Sheidaie A; Koletzko B; Uhl O; Djazayery A
    J Proteome Res; 2018 Apr; 17(4):1452-1462. PubMed ID: 29493238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based Cohort.
    Lacruz ME; Kluttig A; Tiller D; Medenwald D; Giegling I; Rujescu D; Prehn C; Adamski J; Frantz S; Greiser KH; Emeny RT; Kastenmüller G; Haerting J
    Circ Cardiovasc Genet; 2016 Dec; 9(6):487-494. PubMed ID: 27784734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective analysis of circulating metabolites and endometrial cancer risk.
    Dossus L; Kouloura E; Biessy C; Viallon V; Siskos AP; Dimou N; Rinaldi S; Merritt MA; Allen N; Fortner R; Kaaks R; Weiderpass E; Gram IT; Rothwell JA; Lécuyer L; Severi G; Schulze MB; Nøst TH; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Gurrea AB; Schmidt JA; Palli D; Agnoli C; Tumino R; Sacerdote C; Mattiello A; Vermeulen R; Heath AK; Christakoudi S; Tsilidis KK; Travis RC; Gunter MJ; Keun HC
    Gynecol Oncol; 2021 Aug; 162(2):475-481. PubMed ID: 34099314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
    Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC.
    Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Sieri S; Tumino R; Bueno-de-Mesquita B; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Larrañaga N; Perez-Cornago A; Assi N; Riboli E; Tsilidis KK; Key TJ; Travis RC
    Int J Cancer; 2020 Feb; 146(3):720-730. PubMed ID: 30951192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes.
    Ha CY; Kim JY; Paik JK; Kim OY; Paik YH; Lee EJ; Lee JH
    Clin Endocrinol (Oxf); 2012 May; 76(5):674-82. PubMed ID: 21958081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective analysis of circulating metabolites and breast cancer in EPIC.
    His M; Viallon V; Dossus L; Gicquiau A; Achaintre D; Scalbert A; Ferrari P; Romieu I; Onland-Moret NC; Weiderpass E; Dahm CC; Overvad K; Olsen A; Tjønneland A; Fournier A; Rothwell JA; Severi G; Kühn T; Fortner RT; Boeing H; Trichopoulou A; Karakatsani A; Martimianaki G; Masala G; Sieri S; Tumino R; Vineis P; Panico S; van Gils CH; Nøst TH; Sandanger TM; Skeie G; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Schmidt JA; Travis RC; Riboli E; Tsilidis KK; Christakoudi S; Gunter MJ; Rinaldi S
    BMC Med; 2019 Sep; 17(1):178. PubMed ID: 31547832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered levels of acylcarnitines, phosphatidylcholines, and sphingomyelins in peritoneal fluid from ovarian endometriosis patients.
    Vouk K; Ribič-Pucelj M; Adamski J; Rižner TL
    J Steroid Biochem Mol Biol; 2016 May; 159():60-9. PubMed ID: 26921767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Lysophosphatidylcholine Acyltransferase 1 and Concomitant Lipid Alterations in Gastric Cancer.
    Uehara T; Kikuchi H; Miyazaki S; Iino I; Setoguchi T; Hiramatsu Y; Ohta M; Kamiya K; Morita Y; Tanaka H; Baba S; Hayasaka T; Setou M; Konno H
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S206-13. PubMed ID: 25752890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma metabolites associated with colorectal cancer stage: Findings from an international consortium.
    Geijsen AJMR; van Roekel EH; van Duijnhoven FJB; Achaintre D; Bachleitner-Hofmann T; Baierl A; Bergmann MM; Boehm J; Bours MJL; Brenner H; Breukink SO; Brezina S; Chang-Claude J; Herpel E; de Wilt JHW; Gicquiau A; Gigic B; Gumpenberger T; Hansson BME; Hoffmeister M; Holowatyj AN; Karner-Hanusch J; Keski-Rahkonen P; Keulen ETP; Koole JL; Leeb G; Ose J; Schirmacher P; Schneider MA; Schrotz-King P; Stift A; Ulvik A; Vogelaar FJ; Wesselink E; van Zutphen M; Gsur A; Habermann N; Kampman E; Scalbert A; Ueland PM; Ulrich AB; Ulrich CM; Weijenberg MP; Kok DE
    Int J Cancer; 2020 Jun; 146(12):3256-3266. PubMed ID: 31495913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum metabolic profiling using small molecular water-soluble metabolites in individuals with schizophrenia: A longitudinal study using a pre-post-treatment design.
    Cao B; Jin M; Brietzke E; McIntyre RS; Wang D; Rosenblat JD; Ragguett RM; Zhang C; Sun X; Rong C; Wang J
    Psychiatry Clin Neurosci; 2019 Mar; 73(3):100-108. PubMed ID: 30156046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study.
    Yin MZ; Tan S; Li X; Hou Y; Cao G; Li K; Kou J; Lou G
    Tumour Biol; 2016 Apr; 37(4):5485-92. PubMed ID: 26566624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition.
    Breeur M; Ferrari P; Dossus L; Jenab M; Johansson M; Rinaldi S; Travis RC; His M; Key TJ; Schmidt JA; Overvad K; Tjønneland A; Kyrø C; Rothwell JA; Laouali N; Severi G; Kaaks R; Katzke V; Schulze MB; Eichelmann F; Palli D; Grioni S; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Olsen KS; Sandanger TM; Nøst TH; Quirós JR; Bonet C; Barranco MR; Chirlaque MD; Ardanaz E; Sandsveden M; Manjer J; Vidman L; Rentoft M; Muller D; Tsilidis K; Heath AK; Keun H; Adamski J; Keski-Rahkonen P; Scalbert A; Gunter MJ; Viallon V
    BMC Med; 2022 Oct; 20(1):351. PubMed ID: 36258205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
    Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
    BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Stability of Human Plasma Metabolites during Storage at -80 °C.
    Haid M; Muschet C; Wahl S; Römisch-Margl W; Prehn C; Möller G; Adamski J
    J Proteome Res; 2018 Jan; 17(1):203-211. PubMed ID: 29064256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer.
    Goto T; Terada N; Inoue T; Kobayashi T; Nakayama K; Okada Y; Yoshikawa T; Miyazaki Y; Uegaki M; Utsunomiya N; Makino Y; Sumiyoshi S; Yamasaki T; Kamba T; Ogawa O
    Prostate; 2015 Dec; 75(16):1821-30. PubMed ID: 26332786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.